Clinical trials
Phase 4 Heart Failure, Systolic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 7 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 10 |
| Enrolling by invitation | 3 |
| Recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Queen's University | 2 |
| Aarhus University Hospital | 1 |
| Ascension Health | 1 |
| Bispebjerg Hospital | 1 |
| Collegium Medicum w Bydgoszczy | 1 |
| Gødstrup Hospital | 1 |
| Hospital General de Agudos "Dr. Cosme Argerich" | 1 |
| Hospital Moinhos de Vento | 1 |
| Kaohsiung Veterans General Hospital. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure, Systolic | 29 |
| Heart Failure | 12 |
| Iron Deficiencies | 2 |
| Alzheimer Disease | 1 |
| Anemia, Iron-Deficiency | 1 |
| Atrial Remodeling | 1 |
| Cardiomyopathies | 1 |
| Cardiomyopathy, Dilated | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Dilatation, Pathologic | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.